Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Xiaoyi Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4061-910X; OpenAlex author ID A5103092984. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. Advances in the application of extracellular vesicles in precise diagnosis of pancreatic cancer. Last author DOI 10.1186/s40001-025-02739-5↗
  2. Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s12094-022-02864-1↗
  3. Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_1663_20↗
  4. OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngen… Last author PMID 34249428↗
  5. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. Co-author DOI 10.1016/j.apsb.2019.11.013↗
  6. Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy. Co-author DOI 10.1039/d0tb00017e↗
  7. Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Co-author DOI 10.3748/wjg.v24.i46.5280↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu Zhou · 3 shared papers, 2020–2022 · strength 0.41
  2. Qingbing Wang · 3 shared papers, 2020–2021 · strength 0.37
  3. Haiyang Yu · 1 shared paper, 2025 · strength 0.37
  4. Qiwei Zhang · 2 shared papers, 2021–2022 · strength 0.30
  5. Zhongmin Wang · 2 shared papers, 2018–2020 · strength 0.19
  6. Wei Huang · 2 shared papers, 2018–2020 · strength 0.19
  7. Yongsheng Jiang · 1 shared paper, 2022 · strength 0.15
  8. Fuyou Li · 1 shared paper, 2020 · strength 0.11
  9. Tao Sun · 1 shared paper, 2020 · strength 0.11
  10. Chen Jiang · 1 shared paper, 2020 · strength 0.11
  11. Chen Jiang · 1 shared paper, 2020 · strength 0.11
  12. Qinjun Chen · 1 shared paper, 2020 · strength 0.11
  13. Wenxi Zhou · 1 shared paper, 2020 · strength 0.11
  14. Xinli Chen · 1 shared paper, 2020 · strength 0.11
  15. Yingtian Wei · 1 shared paper, 2021 · strength 0.08
  16. Chengli Li · 1 shared paper, 2021 · strength 0.08
  17. Tianan Jiang · 1 shared paper, 2021 · strength 0.08
  18. Yinying Lu · 1 shared paper, 2021 · strength 0.08
  19. Liwei Wang · 1 shared paper, 2021 · strength 0.08
  20. Ming Kuang · 1 shared paper, 2021 · strength 0.08
  21. Junhui Sun · 1 shared paper, 2021 · strength 0.08
  22. Haipeng Yu · 1 shared paper, 2021 · strength 0.08
  23. Kai‐Wen Huang · 1 shared paper, 2021 · strength 0.08
  24. Yingxun Zhang · 1 shared paper, 2021 · strength 0.08
  25. Maoquan Li · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.